Synfini Company

Synfini provides an AI-powered drug discovery platform that supports the full chemistry workflow—from molecular design through synthesis, testing, analysis, and data management. Its suite includes SynPlan for project planning and tracking, SynDesign for generating optimized molecules with minimal data, SynRoute for AI-assisted synthesis pathway planning, SynBuild for automated compound production, and SynDB as a centralized reaction and molecular data repository. The platform enables scientists to collaborate seamlessly, customize workflows, and accelerate hit-to-lead and lead optimization stages with efficiency and precision. Synfini also engages in partnerships with biotech firms like Multispan and O₂nix Bio to apply its integrated design-make-test-analyze system to challenging targets such as GPCRs and cancer‑related enzymes.

Total Funding: 8900000
Founded Date: 2023-01-01
Industry: Quantum Chemistry
Last Funding Date: 2025-07-07
Funding Status: private
Headquarters: Menlo Park,California,United States,North America
Super Industry: Quantum Science Applications
Funding Total Value: 8900000
Last Funding Total Usd: 8900000
Last Funding Total Currency: USD
Last Funding Total Value: 8900000
Founders: Doug Donzelli,Nathan Collins,Peter Madrid
Phone Number: 650-283-5939